Biotech & Pharma

Drug Target for Fragile X Syndrome Identified Through Preclinical Study

26 sec read14 views0 listens

UCLA Health researchers have identified EPAC2, a synaptic protein, as a potential therapeutic target for treating fragile X syndrome (FXS) through preclinical studies in mice. This discovery is significant because it addresses the excitation/inhibition imbalance characteristic of FXS and could lead to targeted therapies with fewer side effects, advancing efforts to develop effective treatments for this genetic disorder.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Carrie Underwood's longevity routine includes eating more protein, gardening, and hundreds of push-ups

Carrie Underwood emphasizes longevity through gardening, push-up workouts, and a protein-rich diet. This routine is crucial for active individuals seeking to maintain fitness and health into old age. Her new protein powder mix highlights the growing ...

Ali Nemati

Health & MedicineApr 2727 sec read

STAT+: Zap in a cap: How one neurotech startup is using a hat to treat depression

Motif Neurotech received FDA approval to begin a feasibility trial for their device, which uses an implanted brain stimulator activated by wearing a hat to treat treatment-resistant depression. This development offers tech professionals and developer...

Ali Nemati

AI & Machine LearningApr 2658 sec read

Hierarchical Sales Target Cascading using Directed Acyclic Graphs (DAGs) in Python

To implement a pipeline-aware quota redistribution system that ensures fairness and operational health while adhering to strict constraints, we need to follow these steps: Diagnose Pipeline Health: This involves calculating the coverage ratio (Curre...

Ali Nemati

AI & Machine LearningApr 1123 sec read

The GLP-1 gold rush is creating winners far beyond pharma

The surge in GLP-1 drug usage is driving significant financial impacts beyond the pharmaceutical industry, affecting sectors like fitness, fashion, supplements, and plastic surgery. This trend matters to developers and tech professionals as it highli...

Ali Nemati

AI & Machine LearningApr 425 sec read

When I became a dad, I experienced postpartum depression. My whole life changed, and I no longer understood who I was.

A new father experiences postpartum depression after his son's birth, leading to a loss of identity and joy. He recovers with medication, therapy, and support from loved ones, highlighting the importance of empathy and open dialogue for mental health...

Ali Nemati

Drug Target for Fragile X Syndrome Identified Through Preclinical Study

Related Articles

Carrie Underwood's longevity routine includes eating more protein, gardening, and hundreds of push-ups

STAT+: Zap in a cap: How one neurotech startup is using a hat to treat depression

Hierarchical Sales Target Cascading using Directed Acyclic Graphs (DAGs) in Python

The GLP-1 gold rush is creating winners far beyond pharma

When I became a dad, I experienced postpartum depression. My whole life changed, and I no longer understood who I was.